July 29, 2020 | Source: MarketWatch
Jul 28, 2020 (AB Digital via COMTEX) — Irvine, California, USA – In the battle against COVID-19, Matregenix Inc., a California-based Medtech company has developed a proprietary highly breathable nanofiber filter membrane media that has a filtration efficiency of over 99%. This membrane is 100% antimicrobial with the ability to deactivate various strains of viruses – including human coronavirus.
According to Dr. Sherif Soliman, founder and CEO of Matregenix, “This technology has been properly verified and tested by leading third-party testing labs and will be significant when applied to surgical masks and respirators.”
The illustration shows the nanofibers in grey and the virus in brown
“Engineering the pores in the active filtration layer without compromising the surface area of the fibers that make up the membrane is a difficult but achievable task using electrospinning technology. Our process also allows for the incorporation of antiviral compounds into nanofibers in a single manufacturing step,” stated Dr. Kevin Guo, COO of Matregenix.
“Nanofiber adoption in commercial applications has been limited due to a deficient understanding of large-scale production requirements in this specialized field. Our team’s experience and understanding of this medium uniquely position us to take this success in the lab and translate them into commercial-grade products,” said Soliman, while announcing the release of the innovative membrane.
The structure of nanofiber media makes them an exceptional material for blocking fine dust particles, aerosols, bacteria, or viruses. Nanofiber based filters provide better filtration performance compared with conventional melt-blown materials at a significantly lighter weight. Thanks to the sophisticated technologies employed by Matregenix, this novel membrane can be used for various applications such as hospital gowns, medical head and shoe covers, protective apparel, HVAC filters for home, office, and hospital use, HEPA filters for airplanes, cruise ships, etc.
About the Company:
Matregenix Inc. is a California-based MedTech company that designs, develops, and manufactures highly tunable nanofibrous materials adaptable to the customized needs in a wide range of applications. The Matregenix team, with a combined 30 years of experience in nanofiber research is equipped with state-of-the-art industrial nanofiber production equipment. The company is currently exploring potential applications for its revolutionary filter membrane technology.
For more information, visit www.matregenix.com